| scholarly article | Q13442814 |
| P50 | author | Jianxin Sun | Q42616615 |
| P2093 | author name string | Ping Yang | |
| Ming Chen | |||
| Bing Yi | |||
| Qing Qin | |||
| Xiaohua You | |||
| P2860 | cites work | Endothelin and endothelin receptors in the renal and cardiovascular systems | Q26862460 |
| Conversion of Bcl-2 from protector to killer by interaction with nuclear orphan receptor Nur77/TR3 | Q28246420 | ||
| Vascular endothelin receptor type B: structure, function and dysregulation in vascular disease | Q28263963 | ||
| Neuroprotection by histone deacetylase-7 (HDAC7) occurs by inhibition of c-jun expression through a deacetylase-independent mechanism | Q28568359 | ||
| Estradiol attenuates hypoxia-induced pulmonary endothelin-1 gene expression | Q28570520 | ||
| AP-1 as a regulator of cell life and death | Q29616558 | ||
| Endothelins and endothelin receptor antagonists: therapeutic considerations for a novel class of cardiovascular drugs | Q31531733 | ||
| Vezf1/DB1 is an endothelial cell-specific transcription factor that regulates expression of the endothelin-1 promoter | Q31814866 | ||
| Green tea polyphenol epigallocatechin gallate reduces endothelin-1 expression and secretion in vascular endothelial cells: roles for AMP-activated protein kinase, Akt, and FOXO1 | Q33577496 | ||
| Molecular regulation of the endothelin-1 gene by hypoxia. Contributions of hypoxia-inducible factor-1, activator protein-1, GATA-2, AND p300/CBP. | Q33940517 | ||
| Endothelial dysfunction and atherosclerosis: endothelin receptor antagonists as novel therapeutics | Q34028426 | ||
| c-Jun and the transcriptional control of neuronal apoptosis | Q34047159 | ||
| High density lipoproteins stimulate the production and secretion of endothelin-1 from cultured bovine aortic endothelial cells | Q34131715 | ||
| Endothelin-1 gene regulation | Q34421747 | ||
| Targeting Nur77 translocation | Q34588195 | ||
| The endothelin system in pulmonary arterial hypertension | Q35635106 | ||
| The NR4A subfamily of nuclear receptors: new early genes regulated by growth factors in vascular cells. | Q36017199 | ||
| Orphan nuclear receptor TR3/Nur77 regulates VEGF-A-induced angiogenesis through its transcriptional activity | Q36228417 | ||
| Biphasic increase in c-jun mRNA is required for induction of AP-1-mediated gene transcription: differential effects of muscarinic and thrombin receptor activation | Q36703723 | ||
| Mechanisms of ET-1-induced endothelial dysfunction | Q37037144 | ||
| Endothelin--role in vascular disease | Q37265810 | ||
| Synergistic induction of endothelin-1 by tumor necrosis factor alpha and interferon gamma is due to enhanced NF-kappaB binding and histone acetylation at specific kappaB sites | Q37433354 | ||
| NR4All in the vessel wall | Q37833366 | ||
| c-Jun, at the crossroad of the signaling network | Q37969687 | ||
| Endothelin receptor antagonists for the treatment of pulmonary artery hypertension | Q38033905 | ||
| Cytosporone B is an agonist for nuclear orphan receptor Nur77. | Q39952461 | ||
| 6-Mercaptopurine, an activator of Nur77, enhances transcriptional activity of HIF-1alpha resulting in new vessel formation | Q40200614 | ||
| Circulating and tissue endothelin immunoreactivity in advanced atherosclerosis | Q41160044 | ||
| Peroxisome proliferator-activated receptor activators inhibit thrombin-induced endothelin-1 production in human vascular endothelial cells by inhibiting the activator protein-1 signaling pathway | Q42477113 | ||
| NR4A1 (Nur77) deletion polarizes macrophages toward an inflammatory phenotype and increases atherosclerosis | Q42573987 | ||
| Regulation of endothelin-1 gene expression by Fos and Jun. | Q44491830 | ||
| Downregulation of endothelin-1 by farnesoid X receptor in vascular endothelial cells | Q46853309 | ||
| Vascular gene expression in mice overexpressing human endothelin-1 targeted to the endothelium. | Q50556171 | ||
| Increased tissue endothelin immunoreactivity in atherosclerotic lesions associated with acute coronary syndromes. | Q50767621 | ||
| The orphan nuclear receptor Nur77 suppresses endothelial cell activation through induction of IkappaBalpha expression. | Q51824215 | ||
| Activation of nuclear receptor Nur77 by 6-mercaptopurine protects against neointima formation. | Q53575755 | ||
| Both ETA and ETB receptors mediate contraction to endothelin-1 in human blood vessels. | Q54212669 | ||
| Bone Marrow–Specific Deficiency of Nuclear Receptor Nur77 Enhances Atherosclerosis | Q63917005 | ||
| The role of c-Jun protein in thrombin-stimulated expression of preproendothelin-1 mRNA in porcine aortic endothelial cells | Q72870655 | ||
| Thrombin induces endothelin expression in arterial smooth muscle cells | Q73698519 | ||
| Dexamethasone inhibits stimulation of pulmonary endothelins by proinflammatory cytokines: possible involvement of a nuclear factor kappa B dependent mechanism | Q73997319 | ||
| 6-Mercaptopurine reverses experimental vasospasm and alleviates the production of endothelins in NO-independent mechanism-a laboratory study | Q82954015 | ||
| Nuclear receptor Nur77 inhibits vascular outward remodelling and reduces macrophage accumulation and matrix metalloproteinase levels | Q83067693 | ||
| P921 | main subject | endothelium | Q111140 |
| P304 | page(s) | 20-28 | |
| P577 | publication date | 2014-10-02 | |
| P1433 | published in | Journal of Molecular and Cellular Cardiology | Q2061932 |
| P1476 | title | Orphan nuclear receptor Nur77 is a novel negative regulator of endothelin-1 expression in vascular endothelial cells | |
| P478 | volume | 77 |
| Q41900644 | Berberine protects vascular endothelial cells in hypertensive rats |
| Q52338555 | Mechanotransduction in Coronary Vein Graft Disease. |
| Q58801877 | Nuclear Receptor Nur77 Deficiency Alters Dendritic Cell Function |
| Q38378655 | Nuclear receptors in vascular biology. |
| Q37549431 | Nur77 attenuates endothelin-1 expression via downregulation of NF-κB and p38 MAPK in A549 cells and in an ARDS rat model |
| Q51312490 | Nur77 downregulation triggers pulmonary artery smooth muscle cell proliferation and migration in mice with hypoxic pulmonary hypertension via the Axin2-β-catenin signaling pathway. |
| Q36033395 | Orphan Nuclear Receptor Nur77 Inhibits Cardiac Hypertrophic Response to Beta-Adrenergic Stimulation |
| Q64121507 | The Mechanism of Acupuncture in Treating Essential Hypertension: A Narrative Review |
| Q90101156 | Transcriptional up-regulation of relaxin-3 by Nur77 attenuates β-adrenergic agonist-induced apoptosis in cardiomyocytes |
Search more.